Idanna Innocenti

1.6k total citations
75 papers, 638 citations indexed

About

Idanna Innocenti is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Idanna Innocenti has authored 75 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 27 papers in Pathology and Forensic Medicine and 24 papers in Immunology. Recurrent topics in Idanna Innocenti's work include Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Idanna Innocenti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Idanna Innocenti collaborates with scholars based in Italy, United States and Japan. Idanna Innocenti's co-authors include Luca Laurenti, Francesco Autore, Dimitar G. Efremov, Simona Sica, Federica Sorà, Stefania Gobessi, Binu K. Sasi, Kamil Bojarczuk, Gabriele Pozzato and Patrizia Chiusolo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Idanna Innocenti

69 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Idanna Innocenti Italy	14	336	227	181	173	152	75	638
Radovan Vrḫovac Croatia	15	330 1.0×	227 1.0×	157 0.9×	223 1.3×	243 1.6×	65	810
Sandra Quijano Colombia	13	250 0.7×	236 1.0×	130 0.7×	148 0.9×	143 0.9×	40	661
Chun Qiao China	15	322 1.0×	179 0.8×	224 1.2×	318 1.8×	353 2.3×	100	825
Adam S. Kittai United States	13	301 0.9×	252 1.1×	157 0.9×	145 0.8×	87 0.6×	79	690
Gaetano Vitelli Italy	14	298 0.9×	158 0.7×	154 0.9×	308 1.8×	130 0.9×	28	673
Giovanna Suppo Italy	11	331 1.0×	191 0.8×	183 1.0×	323 1.9×	356 2.3×	15	841
M Marinelli Italy	16	532 1.6×	396 1.7×	293 1.6×	228 1.3×	79 0.5×	48	788
Łukasz Bołkuń Poland	14	111 0.3×	78 0.3×	158 0.9×	187 1.1×	181 1.2×	52	510
Antonella Teramo Italy	16	282 0.8×	271 1.2×	402 2.2×	99 0.6×	77 0.5×	38	722
Carmelo Gurnari Italy	19	324 1.0×	93 0.4×	208 1.1×	364 2.1×	592 3.9×	141	1.0k

Countries citing papers authored by Idanna Innocenti

Since Specialization

Citations

This map shows the geographic impact of Idanna Innocenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idanna Innocenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idanna Innocenti more than expected).

Fields of papers citing papers by Idanna Innocenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Idanna Innocenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idanna Innocenti. The network helps show where Idanna Innocenti may publish in the future.

Co-authorship network of co-authors of Idanna Innocenti

This figure shows the co-authorship network connecting the top 25 collaborators of Idanna Innocenti. A scholar is included among the top collaborators of Idanna Innocenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Idanna Innocenti. Idanna Innocenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Innocenti, Idanna, et al.. (2024). Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed. Cancers. 16(11). 2011–2011. 2 indexed citations

D’Arena, Giovanni, Candida Vitale, Giuseppe Pietrantuono, et al.. (2024). What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers. 16(2). 469–469. 3 indexed citations

Innocenti, Idanna, Michela Tarnani, Eugenio Galli, et al.. (2023). Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience. Cancers. 15(23). 5592–5592. 2 indexed citations

Innocenti, Idanna, Eugenio Galli, Patrizia Chiusolo, et al.. (2023). Prevention of CINV in Patients with Multiple Myeloma or Lymphoma Undergoing Hematopoietic Stem Cell Transplantation: NEPA Versus Ondansetron. a Monocentric Real-Life Experience. Blood. 142(Supplement 1). 7067–7067.

Galli, Eugenio, Silvia Bellesi, Elisabetta Metafuni, et al.. (2023). Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management. European Journal Of Haematology. 112(2). 184–196. 12 indexed citations

Galli, Eugenio, Federica Sorà, Stefan Hohaus, et al.. (2022). Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells. British Journal of Haematology. 201(1). 86–94. 29 indexed citations

Galli, Eugenio, Federica Sorà, Sabrina Giammarco, et al.. (2022). Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia. Supportive Care in Cancer. 30(6). 4953–4959. 5 indexed citations

Galli, Eugenio, Elisabetta Metafuni, Sabrina Giammarco, et al.. (2022). Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. Bone Marrow Transplantation. 57(4). 532–537. 8 indexed citations

Autore, Francesco, et al.. (2021). Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review. Journal of Clinical Medicine. 10(21). 5104–5104. 6 indexed citations

10.

Chiusolo, Patrizia, Francesco Autore, Sabrina Giammarco, et al.. (2021). IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021062–e2021062. 2 indexed citations

11.

Autore, Francesco, Patrizia Chiusolo, Federica Sorà, et al.. (2021). Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience. Frontiers in Oncology. 11. 614721–614721. 9 indexed citations

12.

Sorà, Federica, Patrizia Chiusolo, Luca Laurenti, et al.. (2020). SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation. Transfusion and Apheresis Science. 59(6). 102881–102881. 5 indexed citations

13.

Autore, Francesco, Idanna Innocenti, Francesco Corrente, et al.. (2020). Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region. Frontiers in Oncology. 10. 848–848. 2 indexed citations

14.

Gobessi, Stefania, Luca Laurenti, Fabiola Porro, et al.. (2018). Serum IgM/Fcmr Interactions Inhibit BCR Signaling and Influence the Cinical Course of CLL. Blood. 132(Supplement 1). 4409–4409. 1 indexed citations

15.

Luca, Luciana De, Giovanni D’Arena, Vittorio Simeon, et al.. (2016). Characterization and Prognostic Relevance of Circulating Microvesicles in Chronic Lymphocytic Leukemia. Blood. 128(22). 4375–4375. 1 indexed citations

16.

Autore, Francesco, Paolo Strati, Idanna Innocenti, et al.. (2016). LDH Levels Predict Progression-Free Survival in Treatment-NaÏVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia. Blood. 128(22). 3211–3211. 2 indexed citations

17.

Laurenti, Luca, Barbara Vannata, Idanna Innocenti, et al.. (2013). CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013031–e2013031. 9 indexed citations

18.

Laurenti, Luca, Barbara Vannata, Idanna Innocenti, et al.. (2011). New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia. Mini-Reviews in Medicinal Chemistry. 11(6). 508–518. 3 indexed citations

19.

Palladino, Mariangela, Luca Laurenti, Patrizia Chiusolo, et al.. (2010). Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients. Acta Haematologica. 123(4). 230–234. 9 indexed citations

20.

Laurenti, Luca, Michela Tarnani, Dimitar G. Efremov, et al.. (2008). Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration. Annals of Hematology. 87(11). 891–898. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact